1-1 of 1
Joshua B. Kitner
Close
Sort by
Journal Articles

KRN5500: a novel therapeutic agent with in vitro activity against human B-cell chronic lymphocytic leukemia cells mediates cytotoxicity via the intrinsic pathway of apoptosis

John C. Byrd, David M. Lucas, Andrew P. Mone, Joshua B. Kitner, Joseph J. Drabick, Michael R. Grever
Journal: Blood
Blood (2003) 101 (11): 4547–4550.
https://doi.org/10.1182/blood-2002-08-2623
Published: 2003